Multiomics – News and Features

BioSeek will apply its BioMAP® systems to evaluate a number of UCB compounds across several target classes.

The Consortium will be focused on developing systems biology tools for safety assessment of small molecule compounds and biological therapeutics.

ATCC collaborates with The Valley Hospital of Ridgewood, New Jersey to accelerate the development and validation of biomarkers for the early detection and treatment of pancreatic cancer.

The proteomics brochure provides researchers with information on the latest tools for reliable and consistent protein identifications.

Researchers at Dana-Farber Cancer Institute and collaborators have used data on genes involved in inherited forms of breast cancer to identify a gene potentially linked to the disease.

ISB plans to exploit LEAP's in situ live cell manipulation capabilities to enable new approaches to functionally cloning immune cells.

The goal of collaboration is to create a breast cancer patient profile test to improve diagnosis and treatment for individualized medicine.

Members from the Salk Institute for Biological Studies and the University of Marburg joins the RNAi Global initiative.

ToxWiz is a software solution for predicting toxic endpoints and for elucidating mechanisms of toxicity.

The collaboration aim to develop a software suite for the integration and analysis of cystic fibrosis data.